Sinopharm Group Stock

HKD18.72

1.63% today

Hong Kong, Jul 10, 05:59 am CET

ISIN

CNE100000FN7

Symbol

1099

Index

Hang Seng

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts Strategies

Sinopharm Group Stock price

HKD18.42

-1.93 9.48% 5Y

Hong Kong, Closing price Wed, Jul 09 2025

-0.02 0.11%

ISIN

CNE100000FN7

Symbol

1099

Index

Hang Seng

Sector

Health

Industry

Pharmaceuticals

Key metrics

Basic

Market capitalization

HKD57.8b

Enterprise Value

HKD81.9b

Net debt

HKD24.1b

Cash

HKD59.4b

Shares outstanding

3.1b

Valuation (TTM | estimate)

P/E

7.5 | 6.4

P/S

0.1 | 0.1

EV/Sales

0.1 | 0.1

EV/FCF

7.8

P/B

0.7

Dividends

DPS

HKD0.74

Yield 1Y | 5Y

4.0% | 4.3%

Growth 1Y | 5Y

-22.7% | 2.5%

Payout 1Y | 3Y

29.9% | 30.1%

Increased

0 Years

Financials (TTM | estimate)

Revenue

HKD639.0b | HKD666.9b

EBITDA

HKD24.6b | HKD23.3b

EBIT

HKD19.4b | HKD19.9b

Net Income

HKD7.7b | HKD9.0b

Free Cash Flow

HKD10.5b

Growth (TTM | estimate)

Revenue

-2.0% | 4.3%

EBITDA

-15.7% | 8.6%

EBIT

-20.2% | 2.3%

Net Income

-22.1% | 16.1%

Free Cash Flow

-35.5%

Financial Health

Equity Ratio

20.1%

Return on Equity

8.9%

ROCE

12.5%

ROIC

7.4%

Debt/Equity

1.0

EPS

HKD2.5

FCF per Share

HKD3.4

Short interest

Employees

108k

Rev per Employee

HKD5.9m

As a Free StocksGuide user, you can view scores for all 7,004 stocks worldwide.

Get Started for Free Today

Sinopharm Group Stock Analysis

Unlock Scores for Free

??

21 Analysts have issued a Sinopharm Group forecast:

15x Buy

71%

5x Hold

24%

More details on Analyst Estimates Including Price Targets

21 Analysts have issued a Sinopharm Group forecast:

Buy

71%

Hold

24%

Sell

Analyst Estimates with Stock Price Targets

Financial data from Sinopharm Group

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	638,980 638,980	2% 2% 100%
- Direct Costs	590,600 590,600	1% 1% 92%
Gross Profit	48,380 48,380	9% 9% 8%
- Selling and Administrative Expenses	29,465 29,465	1% 1% 5%
- Research and Development Expense	- -	- -
EBITDA	24,601 24,601	16% 16% 4%
- Depreciation and Amortization	5,175 5,175	7% 7% 1%
EBIT (Operating Income) EBIT	19,427 19,427	20% 20% 3%
Net Profit	7,707 7,707	22% 22% 1%

In millions HKD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Head office	China
Employees	108,217
Founded	2003
Website	www.sinopharmgroup.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now